Logo image
Biallelic SLC13A1 loss-of-function variants result in impaired sulfate transport and skeletal phenotypes including short stature, scoliosis, and skeletal dysplasia
Journal article   Open access   Peer reviewed

Biallelic SLC13A1 loss-of-function variants result in impaired sulfate transport and skeletal phenotypes including short stature, scoliosis, and skeletal dysplasia

Christina G. Tise, Katie Ashton, Lachlan de Hayr, Kun-Di Lee, Omkar L. Patkar, Emma Krzesinski, Jennifer A. Bassetti, Erin M. Carter, Cathleen Raggio, Andreas Zankl, …
Genetics in Medicine Open, Vol.3, pp.1-13
2025
PMCID: PMC11803892
PMID: 39925707
pdf
preproof2.22 MBDownloadView
Accepted Version Open Access CC BY V4.0
url
https://doi.org/10.1016/j.gimo.2024.101958View
Published Version

Abstract

hyposulfatemia scoliosis short stature skeletal dysplasia sulfate transporter
Purpose Sulfate is vital for many physiological processes, including the structural and functional maintenance of macromolecules and formation of sulfur-containing compounds essential for cartilage and bone development. SLC13A1 is a sodium-sulfate co-transporter primarily expressed in the kidney, where it mediates sulfate reabsorption and maintenance of circulating sulfate levels. In this study, we characterized the clinical, biochemical, and functional impact of biallelic SLC13A1 nonsense and/or missense variants in individuals presenting with a skeletal phenotype. Methods Probands were identified by exome or genome sequencing and GeneMatcher. Sulfate levels were quantified using ion chromatography. SLC13A1 missense variants p.(Arg237Cys), p.(Gly448Asp), p.(Leu516Pro), and p.(Tyr582His) were characterized using bioinformatics, molecular modeling, and [35S]-sulfate uptake assays in MDCK cells. Results All probands presented with concern for short stature and were found to have scoliosis and/or skeletal dysplasia. A reduction in plasma sulfate level and/or increase in urinary sulfate excretion was detected in 2 of 2 probands evaluated. Functional studies were consistent with SLC13A1 variants resulting in complete loss of sulfate transport activity. Conclusion Biallelic loss-of-function variants in SLC13A1 are a novel cause of skeletal phenotypes in humans with a measurable biomarker. Sulfate measurements should be considered in the clinical interpretation of variants identified in SLC13A1.

Details

Metrics

50 File views/ downloads
47 Record Views
Logo image